Domain Therapeutics' Bridge Round

Domain Therapeutics raised a round of funding on October 20, 2006.

Domain Therapeutics, formerly Faust Pharmaceuticals, is a biopharmaceutical company dedicated to the discovery and early development of small molecules targeting G-Protein Coupled Receptors (GPCRs). D…

Articles about Domain Therapeutics' Bridge Round: